Diffuse large B-cell lymphoma-treatment approaches in the molecular era. - Wikidata - awgldk - TriplyDB

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

http://www.wikidata.org/entity/Q38161760

about

The paracaspase MALT1: biological function and potential for therapeutic inhibition Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma The genetic landscape of diffuse large B-cell lymphoma Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma.c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.Expression levels of TWIST1 are associated with the clinicopathological stage of B-cell non-Hodgkin lymphoma.B-cell receptor signaling in diffuse large B-cell lymphoma.DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies.Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution.Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.Machine Learning-based Classification of Diffuse Large B-cell Lymphoma Patients by Their Protein Expression Profiles.Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma.CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Precision monitoring takes the stage Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico.Prediction of survival of diffuse large B-cell lymphoma patients via the expression of three inflammatory genes.New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma.RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era

P2860

Q26778357-623A1BD0-E5F0-4401-B4FE-154BB0C5569C Q26853170-2DA7F7C5-D64D-450E-80B5-1C5D7575A57C Q26866537-7800FF8D-AB3A-4243-BB6C-A7564B4A9E66 Q27304386-334A23D4-ABA0-4DBD-B2D7-484076518A9D Q28067817-4DCDE6AD-0242-4DF7-BD00-CCC51D0DFA95 Q28078869-C3A81492-1CCF-48DC-A391-A9D2B2553A00 Q28551184-FDFA023A-6B3D-4728-8A0D-5EA835BB717F Q31095260-0F2DBF23-51E2-4E62-B5E1-2B2FFBF10BF0 Q33622342-139F85BC-0ACB-4530-B302-B1D75EE4237F Q33798371-437D31AF-5001-4F49-B92B-828E3EBBAB6B Q33815997-36DFB7B0-1202-46A7-BC48-7703B21D9851 Q34292362-BD54F740-7EB4-4A22-B74C-8892486200BA Q35218042-84155BE9-5A21-47B8-ABFF-86ACEB23A74F Q35568457-7AEC9DDD-A56D-4646-B1A5-9D814180A157 Q35764587-B8A1F688-8013-4465-A1FD-C3256458D78D Q35954113-933028F3-7279-4546-A712-A24BB9C49388 Q36011142-30E209AA-1289-476E-8461-75BCE4BF90E1 Q36020841-85D89592-A8F7-494E-AD4A-61054F0553DE Q36217436-571F51AB-5E03-47BE-8F52-03E1227F0BBD Q36263022-D60C8198-7718-4B10-953C-EE10F0BD3D7A Q36544524-276BAD81-91BD-42D5-A2B9-21415B4EA468 Q36890570-060DADCC-30DD-4BF6-8E75-AD7A46ECAB5C Q36920426-B19588B2-4EFF-4C70-BD62-1C7B00E6F1CF Q36934345-E981EFFA-11F5-43B2-8044-C4AA643DD51A Q36948524-BA519D39-7B86-433E-8C4D-E2A47EF49527 Q37035820-064217E7-CE8B-4CFB-9550-49C0A5231167 Q37097081-080D09FB-7A9C-44F3-B50E-D039DC3708DC Q37120620-D679381A-7418-429B-A716-4A7CEC28B209 Q37120684-F9E8CC74-6474-40CE-B81B-42741AC08699 Q37148950-BC328F63-F4C5-4FE2-98DC-F032E4477C32 Q37254890-A0F9FED4-C4FA-4454-A9A4-74A152E80558 Q37520553-1F153D89-BF26-457A-BC7D-EED2233B9BDE Q37610194-10386F68-8653-4A38-B82D-C4689D94BB53 Q37620821-C7933583-A39E-4BE0-BC53-EB65839E981E Q37624237-4566F125-4C3A-40D3-B9F3-51C67F7CAD5D Q37647935-DCDE26D0-1AD1-4675-AE76-8FD513E50C75 Q37683385-72AB1A7E-B753-4F41-8439-EDF253B08C84 Q37699251-D71A322B-A91D-4721-A682-925A6D47CFF6 Q37708919-BFEF566A-1865-4202-B497-532B7F0E65F9 Q37718312-015E490A-7679-438B-BF32-7F249C9FE3AB

P2860

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

http://www.wikidata.org/entity/Q38161760

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

@en

type

label

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

@en

prefLabel

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

@en

P1433

Q38161760-64FE6F14-80D8-4A27-9BF4-3D73094ADDFF

P1476

Q38161760-06D9A891-8841-4102-9D5E-9C7F6330C31D

P2093

Q38161760-D2E49E18-876D-403B-97BC-2DD4BC4B44E6

Q38161760-E03864EA-6480-40EE-AF28-4A692474C48D

Q38161760-E76F4465-E501-4C7E-93AE-232C383732D0

P2860

Q38161760-022D0FDE-BEBD-49D6-B75D-5DE1EE371355

Q38161760-02329125-5CB0-443B-89F2-96B0C6231E17

Q38161760-0C70F058-52A1-4C68-B137-FE898ED3C6D8

Q38161760-0FCFCAC9-9D93-4569-A8CF-ACEE5251BADE

Q38161760-15456E9D-8CD1-4AB2-A3D2-B5B21D61F5C3

Q38161760-1C705FA1-2C83-41E2-B8F4-F54E39A21605

Q38161760-1DDECB2F-4E3D-4F31-8C27-4188FD5A23EF

Q38161760-1E12777A-BE2D-488B-9FA5-A4C42A828AAA

Q38161760-1EE8C3CB-9A67-466F-B3C6-33B40CC3D2AE

Q38161760-20460795-0390-4FD3-B93A-AE2DF2225516

P304

Q38161760-CF709E6D-CC16-43BE-8BA2-4F8D3F180423

P31

Q38161760-52964898-C0BA-4C01-8607-D89398716DFE

P356

Q38161760-E1AAE6E2-AEC4-465B-8F1D-FEBE2FF25A67

P407

Q38161760-386C8794-FFDB-4E71-B8C7-1CDEC1CA092F

P433

Q38161760-7A53CE86-08DD-46D8-99AD-E0B9F4216D56

P478

Q38161760-5F822113-1D28-49C6-8AD7-67D16A94443A

P577

Q38161760-C93F682E-80A1-4E7A-ABD2-D8BA6C7D69C4

P698

Q38161760-C7F8D9AF-83C4-47BF-87D5-374DA888A399

P356

NRCLINONC.2013.197

P1433

Nature Reviews Clinical Oncology

P1476

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

@en

P2093

Louis M Staudt

http://www.w3.org/2001/XMLSchema#string

Mark Roschewski

http://www.w3.org/2001/XMLSchema#string

Wyndham H Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Cooperative epigenetic modulation by cancer amplicon genes

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

P304

12-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2013.197

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24217204

http://www.w3.org/2001/XMLSchema#string